Alterity Therapeutics Ltd ATHE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
1.93quote price arrow down-0.03 (-1.53%)
Volume
3,671
52 week range
1.55 - 5.41
Loading...
  • Open1.95
  • Day High2.02
  • Day Low1.95
  • Prev Close1.96
  • 52 Week High5.41
  • 52 Week High Date12/04/23
  • 52 Week Low1.55
  • 52 Week Low Date02/23/24

Key Stats

  • Market Cap16.872M
  • Shares Out8.74M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change-21.24

KEY STATS

  • Open1.95
  • Day High2.02
  • Day Low1.95
  • Prev Close1.96
  • 52 Week High5.41
  • 52 Week High Date12/04/23
  • 52 Week Low1.55
  • 52 Week Low Date02/23/24
  • Market Cap16.872M
  • Shares Out8.74M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change-21.24

RATIOS/PROFITABILITY

  • EPS (TTM)-2.03
  • P/E (TTM)-0.95
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-9.469M
  • ROE (TTM)-53.72%
  • Revenue (TTM)82,620.002
  • Gross Margin (TTM)-
  • Net Margin (TTM)-9,947.97%
  • Debt To Equity (MRQ)1.45%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alterity Therapeutics Ltd

 

Profile

MORE
Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company’s lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson’s disease, as well as various Parkinsonian disorders...
Geoffrey Kempler
Non-Executive Chairman of the Board
David Stamler M.D.
Chief Executive Officer
Phillip Hains
Chief Financial Officer, Company Secretary
Address
L 3 460 Bourke St
Melbourne, VIC
3000
Australia

Top Peers

SYMBOLLASTCHG%CHG
AKTX
Akari Therapeutics PLC
1.60+0.08+5.26%
ENTO
Entero Therapeutics Inc
2.85UNCHUNCH
OGEN
Oragenics Inc
3.04-0.03-0.98%
ADXS
Ayala Pharmaceuticals Inc
0.30UNCHUNCH
MNPR
Monopar Therapeutics Inc
0.611-0.0089-1.4357%